|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 801 to 900 out of 2570 for Kras

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.041s

Categories

Category: Publication
« show all
Type Details Score
Publication
9133601 | J:39845
First Author: Matzinger SA
Year: 1997
Journal: Gene
Title: Tissue-specific expression of the K-ras allele from the A/J parent in (A/J x TSG-p53) F1 mice.
Volume: 188
Issue: 2
Pages: 261-9
•
•
•
•
•
Publication
9362444 | J:43601
First Author: Pells S
Year: 1997
Journal: Oncogene
Title: Developmentally-regulated expression of murine K-ras isoforms.
Volume: 15
Issue: 15
Pages: 1781-6
•
•
•
•
•
Publication
9744549 | J:49680
First Author: Jones-Bolin SE
Year: 1998
Journal: Carcinogenesis
Title: Effect of promoter and intron 2 polymorphisms on murine lung K-ras gene expression.
Volume: 19
Issue: 8
Pages: 1503-8
•
•
•
•
•
Publication
12106604 | J:78150
First Author: Calvert RJ
Year: 2002
Journal: Biochem Pharmacol
Title: Alterations in membrane-bound and cytoplasmic K-ras protein levels in mouse lung induced by treatment with lovastatin, cholestyramine, or niacin: effects are highly mouse strain dependent.
Volume: 64
Issue: 1
Pages: 41-8
•
•
•
•
•
Publication
12907238 | J:85053
First Author: Calvert RJ
Year: 2003
Journal: Biochem Pharmacol
Title: Treatment with lovastatin, cholestyramine or niacin alters K-ras membrane association in mouse lung in a strain-dependent manner: results in females.
Volume: 66
Issue: 3
Pages: 393-403
•
•
•
•
•
Publication
12963544 | J:86094
First Author: Shimada Y
Year: 2003
Journal: Int J Radiat Biol
Title: Genetic susceptibility to thymic lymphomas and K-ras gene mutation in mice after exposure to X-rays and N-ethyl-N-nitrosourea.
Volume: 79
Issue: 6
Pages: 423-30
•
•
•
•
•
Publication
14713543 | J:88113
First Author: Ton TV
Year: 2004
Journal: Toxicol Pathol
Title: Predominant K-ras codon 12 G --> A transition in chemically induced lung neoplasms in B6C3F1 mice.
Volume: 32
Issue: 1
Pages: 16-21
•
•
•
•
•
Publication
15824019 | J:98658
First Author: Wang M
Year: 2005
Journal: Exp Lung Res
Title: Identification of genetic polymorphisms through comparative DNA sequence analysis on the K-ras gene: implications for lung tumor susceptibility.
Volume: 31
Issue: 2
Pages: 165-77
•
•
•
•
•
Publication
16126346 | J:104887
First Author: Janssen KP
Year: 2005
Journal: Biochim Biophys Acta
Title: Mouse models of K-ras-initiated carcinogenesis.
Volume: 1756
Issue: 2
Pages: 145-54
•
•
•
•
•
Publication
11867530 | J:115358
First Author: Matsui T
Year: 2002
Journal: EMBO J
Title: K-Ras mediates cytokine-induced formation of E-cadherin-based adherens junctions during liver development.
Volume: 21
Issue: 5
Pages: 1021-30
•
•
•
•
•
Publication
17325976 | J:129340
First Author: Hong HH
Year: 2007
Journal: Toxicol Pathol
Title: K-ras mutations in lung tumors and tumors from other organs are consistent with a common mechanism of ethylene oxide tumorigenesis in the B6C3F1 mouse.
Volume: 35
Issue: 1
Pages: 81-5
•
•
•
•
•
Publication
20514414 | J:173667
First Author: Lee S
Year: 2010
Journal: Int J Oncol
Title: Melphalan inhibits adenoma development through modulating the expression of K-ras-specific markers in K-ras Tg mice.
Volume: 37
Issue: 1
Pages: 219-28
•
•
•
•
•
Publication
21875576 | J:177529
First Author: Ohnishi S
Year: 2011
Journal: Biochem Biophys Res Commun
Title: Nitrative and oxidative DNA damage caused by K-ras mutation in mice.
Volume: 413
Issue: 2
Pages: 236-40
•
•
•
•
•
Publication
23665962 | J:198741
First Author: Commisso C
Year: 2013
Journal: Nature
Title: Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells.
Volume: 497
Issue: 7451
Pages: 633-7
•
•
•
•
•
Publication
26773005 | J:229456
First Author: Takano S
Year: 2016
Journal: Genes Dev
Title: Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization.
Volume: 30
Issue: 2
Pages: 233-47
•
•
•
•
•
Publication
26433205 | J:249054
First Author: Zheng J
Year: 2015
Journal: FEBS J
Title: lincRNA-p21 inhibits hepatic stellate cell activation and liver fibrogenesis via p21.
Volume: 282
Issue: 24
Pages: 4810-21
•
•
•
•
•
Publication
30873587 | J:291555
First Author: Duan W
Year: 2019
Journal: Int J Cancer
Title: Type of TP53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung-specific transgenic mice.
Volume: 145
Issue: 9
Pages: 2418-2426
•
•
•
•
•
Publication
31669153 | J:291274
 
First Author: Hochstetler CL
Year: 2019
Journal: Exp Hematol
Title: KRasG12D expression in the bone marrow vascular niche affects hematopoiesis with inflammatory signals.
Volume: 79
Pages: 3-15.e4
•
•
•
•
•
Publication
30931528 | J:295838
First Author: You X
Year: 2019
Journal: Br J Haematol
Title: Systemic Notch downregulation promotes KrasG12D -induced myeloproliferative neoplasm.
Volume: 186
Issue: 3
Pages: e52-e56
•
•
•
•
•
Publication
33441747 | J:300372
First Author: Gutierrez WR
Year: 2021
Journal: Sci Rep
Title: Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models.
Volume: 11
Issue: 1
Pages: 1098
•
•
•
•
•
Publication
31874105 | J:309033
First Author: Valencia K
Year: 2020
Journal: J Clin Invest
Title: The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas.
Volume: 130
Issue: 4
Pages: 1879-1895
•
•
•
•
•
Publication
29956571 | J:310355
First Author: Lin HH
Year: 2018
Journal: Autophagy
Title: Autophagic reliance promotes metabolic reprogramming in oncogenic KRAS-driven tumorigenesis.
Volume: 14
Issue: 9
Pages: 1481-1498
•
•
•
•
•
Publication
23637129 | J:319014
First Author: Shieh A
Year: 2013
Journal: Blood
Title: Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo.
Volume: 121
Issue: 24
Pages: 4884-93
•
•
•
•
•
Publication
23943783 | J:317853
First Author: Dawson DW
Year: 2013
Journal: Cancer Prev Res (Phila)
Title: High-fat, high-calorie diet promotes early pancreatic neoplasia in the conditional KrasG12D mouse model.
Volume: 6
Issue: 10
Pages: 1064-73
•
•
•
•
•
Publication
29438690 | J:257778
First Author: McCormick F
Year: 2018
Journal: Cancer Cell
Title: c-Raf in KRas Mutant Cancers: A Moving Target.
Volume: 33
Issue: 2
Pages: 158-159
•
•
•
•
•
Publication
19060205 | J:142690
First Author: Sharp TV
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development.
Volume: 105
Issue: 50
Pages: 19932-7
•
•
•
•
•
Publication
24890125 | J:213496
First Author: Quintás-Cardama A
Year: 2014
Journal: J Pathol
Title: Loss of the novel tumour suppressor and polarity gene Trim62 (Dear1) synergizes with oncogenic Ras in invasive lung cancer.
Volume: 234
Issue: 1
Pages: 108-19
•
•
•
•
•
Publication
24591640 | J:207384
First Author: Martins M
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Tumor suppressor role of phospholipase C epsilon in Ras-triggered cancers.
Volume: 111
Issue: 11
Pages: 4239-44
•
•
•
•
•
Publication
32767810 | J:299900
First Author: Wang X
Year: 2020
Journal: Cancer Sci
Title: Targeting RNA helicase DHX33 blocks Ras-driven lung tumorigenesis in vivo.
Volume: 111
Issue: 10
Pages: 3564-3575
•
•
•
•
•
Publication
31400748 | J:317466
 
First Author: He Z
Year: 2019
Journal: iScience
Title: Ras Downstream Effector GGCT Alleviates Oncogenic Stress.
Volume: 19
Pages: 256-266
•
•
•
•
•
Publication
26989175 | J:235532
First Author: Dahlhoff M
Year: 2016
Journal: Development
Title: Sebaceous lipids are essential for water repulsion, protection against UVB-induced apoptosis and ocular integrity in mice.
Volume: 143
Issue: 10
Pages: 1823-31
•
•
•
•
•
Publication
18927348 | J:159271
First Author: Moghaddam SJ
Year: 2009
Journal: Am J Respir Cell Mol Biol
Title: Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model.
Volume: 40
Issue: 4
Pages: 443-53
•
•
•
•
•
Publication
32481524 | J:294979
 
First Author: Lee SH
Year: 2020
Journal: Cancers (Basel)
Title: The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer.
Volume: 12
Issue: 6
•
•
•
•
•
Publication
18571763 | J:155787
First Author: Yin X
Year: 2009
Journal: Lung Cancer
Title: Deficiency of a potential 3p21.3 tumor suppressor gene UBE1L (UBA7) does not accelerate lung cancer development in K-rasLA2 mice.
Volume: 63
Issue: 2
Pages: 194-200
•
•
•
•
•
Publication
31316109 | J:283925
First Author: Ritzmann F
Year: 2019
Journal: Sci Rep
Title: IL-17C-mediated innate inflammation decreases the response to PD-1 blockade in a model of Kras-driven lung cancer.
Volume: 9
Issue: 1
Pages: 10353
•
•
•
•
•
Publication
16973961 | J:143675
First Author: Wahlstrom AM
Year: 2007
Journal: Blood
Title: Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease.
Volume: 109
Issue: 2
Pages: 763-8
•
•
•
•
•
Publication
16675706 | J:115068
First Author: Chan IT
Year: 2006
Journal: Blood
Title: Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like disease.
Volume: 108
Issue: 5
Pages: 1708-15
•
•
•
•
•
Publication
31733149 | J:339433
First Author: Ochiai Y
Year: 2020
Journal: Hepatology
Title: Trefoil Factor Family 1 Inhibits the Development of Hepatocellular Carcinoma by Regulating β-Catenin Activation.
Volume: 72
Issue: 2
Pages: 503-517
•
•
•
•
•
Publication
35508175 | J:351204
First Author: Ozturk H
Year: 2022
Journal: Dev Cell
Title: ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer.
Volume: 57
Issue: 11
Pages: 1331-1346.e9
•
•
•
•
•
Publication
28032597 | J:309024
First Author: Hsieh CC
Year: 2017
Journal: Oncotarget
Title: Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasis.
Volume: 8
Issue: 5
Pages: 7691-7709
•
•
•
•
•
Publication
29809170 | J:265680
First Author: Yamaguchi J
Year: 2018
Journal: J Clin Invest
Title: Trefoil factor 1 inhibits epithelial-mesenchymal transition of pancreatic intraepithelial neoplasm.
Volume: 128
Issue: 8
Pages: 3619-3629
•
•
•
•
•
Publication
35471938 | J:326200
 
First Author: Yuan B
Year: 2022
Journal: JCI Insight
Title: Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras-mutant lung cancer.
Volume: 7
Issue: 11
•
•
•
•
•
Publication
19920354 | J:155559
First Author: Santos AM
Year: 2009
Journal: J Clin Invest
Title: Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.
Volume: 119
Issue: 12
Pages: 3613-25
•
•
•
•
•
Publication
37995179 | J:344195
First Author: Yang M
Year: 2023
Journal: Cell Rep
Title: Alveolar type I cells can give rise to KRAS-induced lung adenocarcinoma.
Volume: 42
Issue: 12
Pages: 113286
•
•
•
•
•
Publication
25058882 | J:348820
First Author: Smith JP
Year: 2014
Journal: Pancreas
Title: Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice.
Volume: 43
Issue: 7
Pages: 1050-9
•
•
•
•
•
Publication
33768568 | J:322315
First Author: Di-Luoffo M
Year: 2021
Journal: Hepatology
Title: A Mouse Model of Cholangiocarcinoma Uncovers a Role for Tensin-4 in Tumor Progression.
Volume: 74
Issue: 3
Pages: 1445-1460
•
•
•
•
•
Publication
31577227 | J:290859
   
First Author: Morrow A
Year: 2019
Journal: Elife
Title: Regulated spindle orientation buffers tissue growth in the epidermis.
Volume: 8
•
•
•
•
•
Publication
26477488 | J:231383
First Author: Vasseur R
Year: 2015
Journal: Biochim Biophys Acta
Title: The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
Volume: 1849
Issue: 12
Pages: 1375-84
•
•
•
•
•
Publication
35184157 | J:322705
First Author: Humbert PO
Year: 2022
Journal: Oncogene
Title: TSPAN6 is a suppressor of Ras-driven cancer.
Volume: 41
Issue: 14
Pages: 2095-2105
•
•
•
•
•
Publication
24209743 | J:205132
First Author: Jun S
Year: 2013
Journal: Cell Rep
Title: PAF-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesis.
Volume: 5
Issue: 2
Pages: 314-22
•
•
•
•
•
Publication
38902237 | J:350093
First Author: Martinez S
Year: 2024
Journal: Nat Commun
Title: In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer.
Volume: 15
Issue: 1
Pages: 5266
•
•
•
•
•
Publication
27197187 | J:232036
First Author: Caetano MS
Year: 2016
Journal: Cancer Res
Title: IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.
Volume: 76
Issue: 11
Pages: 3189-99
•
•
•
•
•
Publication
25267066 | J:217190
First Author: Estrach S
Year: 2014
Journal: Cancer Res
Title: CD98hc (SLC3A2) loss protects against ras-driven tumorigenesis by modulating integrin-mediated mechanotransduction.
Volume: 74
Issue: 23
Pages: 6878-89
•
•
•
•
•
Publication
29503447 | J:262377
First Author: Meder L
Year: 2018
Journal: Oncogene
Title: LIN28B enhanced tumorigenesis in an autochthonous KRASG12V-driven lung carcinoma mouse model.
Volume: 37
Issue: 20
Pages: 2746-2756
•
•
•
•
•
Publication
10413402 | J:56444
First Author: Manenti G
Year: 1999
Journal: Genome Res
Title: Linkage disequilibrium and physical mapping of Pas1 in mice.
Volume: 9
Issue: 7
Pages: 639-46
•
•
•
•
•
Publication
26036346 | J:233926
First Author: Tréhoux S
Year: 2015
Journal: Biochim Biophys Acta
Title: Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells.
Volume: 1853
Issue: 10 Pt A
Pages: 2392-403
•
•
•
•
•
Publication
34294846 | J:311003
First Author: Xu G
Year: 2021
Journal: Oncogene
Title: The deubiquitinase USP16 functions as an oncogenic factor in K-RAS-driven lung tumorigenesis.
Volume: 40
Issue: 36
Pages: 5482-5494
•
•
•
•
•
Publication
17404571 | J:163128
First Author: Allen NP
Year: 2007
Journal: Oncogene
Title: RASSF6 is a novel member of the RASSF family of tumor suppressors.
Volume: 26
Issue: 42
Pages: 6203-11
•
•
•
•
•
Publication
3865197 | J:8114
First Author: Guerrero I
Year: 1985
Journal: Proc Natl Acad Sci U S A
Title: Loss of the normal N-ras allele in a mouse thymic lymphoma induced by a chemical carcinogen.
Volume: 82
Issue: 23
Pages: 7810-4
•
•
•
•
•
Publication
14583591 | J:86399
First Author: Zhang Z
Year: 2003
Journal: Proc Natl Acad Sci U S A
Title: Positional cloning of the major quantitative trait locus underlying lung tumor susceptibility in mice.
Volume: 100
Issue: 22
Pages: 12642-7
•
•
•
•
•
Publication
8324828 | J:14935
First Author: Shultz LD
Year: 1993
Journal: Cell
Title: Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene.
Volume: 73
Issue: 7
Pages: 1445-54
•
•
•
•
•
Publication
21339733 | J:174642
First Author: Seux M
Year: 2011
Journal: Oncogene
Title: TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression.
Volume: 30
Issue: 27
Pages: 3049-61
•
•
•
•
•
Publication
19738040 | J:153508
First Author: Regala RP
Year: 2009
Journal: Cancer Res
Title: Atypical protein kinase C{iota} is required for bronchioalveolar stem cell expansion and lung tumorigenesis.
Volume: 69
Issue: 19
Pages: 7603-11
•
•
•
•
•
Publication
30503750 | J:272592
First Author: Farack L
Year: 2019
Journal: Dev Cell
Title: Transcriptional Heterogeneity of Beta Cells in the Intact Pancreas.
Volume: 48
Issue: 1
Pages: 115-125.e4
•
•
•
•
•
Publication
19330036 | J:147455
First Author: Granville CA
Year: 2009
Journal: PLoS One
Title: A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesis.
Volume: 4
Issue: 3
Pages: e5061
•
•
•
•
•
Publication
21317921 | J:173695
First Author: Serres MP
Year: 2011
Journal: Oncogene
Title: Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro.
Volume: 30
Issue: 25
Pages: 2846-58
•
•
•
•
•
Publication
33606996 | J:305988
First Author: Yu M
Year: 2021
Journal: Mol Cell
Title: Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation.
Volume: 81
Issue: 6
Pages: 1216-1230.e9
•
•
•
•
•
Publication
11713472 | J:109368
First Author: Ohno M
Year: 2001
Journal: Nat Neurosci
Title: Inducible, pharmacogenetic approaches to the study of learning and memory.
Volume: 4
Issue: 12
Pages: 1238-43
•
•
•
•
•
Publication
17277161 | J:143972
First Author: Khalaf WF
Year: 2007
Journal: J Immunol
Title: K-ras is critical for modulating multiple c-kit-mediated cellular functions in wild-type and Nf1+/- mast cells.
Volume: 178
Issue: 4
Pages: 2527-34
•
•
•
•
•
Publication
26452035 | J:310992
First Author: Pan Y
Year: 2015
Journal: Oncotarget
Title: Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis.
Volume: 6
Issue: 36
Pages: 38816-26
•
•
•
•
•
Publication
18713982 | J:138959
First Author: Tinder TL
Year: 2008
Journal: J Immunol
Title: MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.
Volume: 181
Issue: 5
Pages: 3116-25
•
•
•
•
•
Publication
30423293 | J:266848
First Author: Volk A
Year: 2018
Journal: Cancer Cell
Title: A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis.
Volume: 34
Issue: 5
Pages: 707-723.e7
•
•
•
•
•
Publication
18264106 | J:204653
First Author: Miller AJ
Year: 2008
Journal: Nat Methods
Title: Tractable Cre-lox system for stochastic alteration of genes in mice.
Volume: 5
Issue: 3
Pages: 227-9
•
•
•
•
•
Publication
24430184 | J:207982
First Author: Li H
Year: 2014
Journal: J Clin Invest
Title: Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis.
Volume: 124
Issue: 2
Pages: 835-46
•
•
•
•
•
Publication
14706336 | J:87973
First Author: Hingorani SR
Year: 2003
Journal: Cancer Cell
Title: Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.
Volume: 4
Issue: 6
Pages: 437-50
•
•
•
•
•
Publication
21512141 | J:172205
First Author: Charles RP
Year: 2011
Journal: Cancer Res
Title: Mutationally activated BRAF(V600E) elicits papillary thyroid cancer in the adult mouse.
Volume: 71
Issue: 11
Pages: 3863-71
•
•
•
•
•
Publication
23999427 | J:203922
First Author: White RA
Year: 2013
Journal: J Clin Invest
Title: Epithelial stem cell mutations that promote squamous cell carcinoma metastasis.
Volume: 123
Issue: 10
Pages: 4390-404
•
•
•
•
•
Publication
23063435 | J:199742
First Author: Peschard P
Year: 2012
Journal: Curr Biol
Title: Genetic deletion of RALA and RALB small GTPases reveals redundant functions in development and tumorigenesis.
Volume: 22
Issue: 21
Pages: 2063-8
•
•
•
•
•
Publication
26996122 | J:234412
First Author: Wang P
Year: 2016
Journal: Int J Cancer
Title: Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer.
Volume: 139
Issue: 3
Pages: 712-8
•
•
•
•
•
Publication
22892241 | J:187371
First Author: Andreadi C
Year: 2012
Journal: Genes Dev
Title: The intermediate-activity (L597V)BRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathway.
Volume: 26
Issue: 17
Pages: 1945-58
•
•
•
•
•
Publication
18614544 | J:138868
First Author: Hegedus B
Year: 2008
Journal: Hum Mol Genet
Title: Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis.
Volume: 17
Issue: 19
Pages: 2956-66
•
•
•
•
•
Publication
23143308 | J:193977
First Author: Maeda Y
Year: 2012
Journal: J Clin Invest
Title: Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.
Volume: 122
Issue: 12
Pages: 4388-400
•
•
•
•
•
Publication
21358804 | J:171087
First Author: Samuel MS
Year: 2011
Journal: PLoS One
Title: K-Ras mediated murine epidermal tumorigenesis is dependent upon and associated with elevated Rac1 activity.
Volume: 6
Issue: 2
Pages: e17143
•
•
•
•
•
Publication
17690114 | J:127727
First Author: Pandey J
Year: 2007
Journal: Carcinogenesis
Title: Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF- b1 haploinsufficiency.
Volume: 28
Issue: 12
Pages: 2589-96
•
•
•
•
•
Publication
29930325 | J:266087
First Author: Liu Y
Year: 2018
Journal: Nat Commun
Title: Mitotic polarization of transcription factors during asymmetric division establishes fate of forming cancer cells.
Volume: 9
Issue: 1
Pages: 2424
•
•
•
•
•
Publication
34020945 | J:314143
 
First Author: Guo Y
Year: 2021
Journal: Sci Adv
Title: Zeb1 induces immune checkpoints to form an immunosuppressive envelope around invading cancer cells.
Volume: 7
Issue: 21
•
•
•
•
•
Publication
39485842 | J:357852
First Author: Mennuni M
Year: 2024
Journal: Sci Adv
Title: High mitochondrial DNA levels accelerate lung adenocarcinoma progression.
Volume: 10
Issue: 44
Pages: eadp3481
•
•
•
•
•
Publication
20421486 | J:160298
First Author: Weinberg F
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.
Volume: 107
Issue: 19
Pages: 8788-93
•
•
•
•
•
Publication
26279302 | J:309335
First Author: Zhang S
Year: 2016
Journal: Oncogene
Title: Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
Volume: 35
Issue: 19
Pages: 2485-95
•
•
•
•
•
Publication
23284900 | J:195622
First Author: Avila JL
Year: 2012
Journal: PLoS One
Title: Notch1 is not required for acinar-to-ductal metaplasia in a model of Kras-induced pancreatic ductal adenocarcinoma.
Volume: 7
Issue: 12
Pages: e52133
•
•
•
•
•
Publication
28288993 | J:243130
First Author: Ajona D
Year: 2017
Journal: Cancer Discov
Title: A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis.
Volume: 7
Issue: 7
Pages: 694-703
•
•
•
•
•
Publication
23395000 | J:196610
First Author: Huber AL
Year: 2013
Journal: Mol Cell
Title: p58(IPK)-mediated attenuation of the proapoptotic PERK-CHOP pathway allows malignant progression upon low glucose.
Volume: 49
Issue: 6
Pages: 1049-59
•
•
•
•
•
Publication
24713656 | J:212762
First Author: Amato KR
Year: 2014
Journal: J Clin Invest
Title: Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC.
Volume: 124
Issue: 5
Pages: 2037-49
•
•
•
•
•
Publication
21625009 | J:174977
First Author: Hollander MC
Year: 2011
Journal: Carcinogenesis
Title: A Cyp2a polymorphism predicts susceptibility to NNK-induced lung tumorigenesis in mice.
Volume: 32
Issue: 8
Pages: 1279-84
•
•
•
•
•
Publication
24018559 | J:203916
First Author: Baek KH
Year: 2013
Journal: J Clin Invest
Title: Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors.
Volume: 123
Issue: 10
Pages: 4375-89
•
•
•
•
•
Publication
22262169 | J:182425
First Author: Walter G
Year: 2012
Journal: Cell Cycle
Title: Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways.
Volume: 11
Issue: 3
Pages: 451-9
•
•
•
•
•
Publication
36598261 | J:352763
First Author: O'Brien VP
Year: 2023
Journal: mBio
Title: Helicobacter pylori Chronic Infection Selects for Effective Colonizers of Metaplastic Glands.
Volume: 14
Issue: 1
Pages: e0311622
•
•
•
•
•
Publication
15024028 | J:89285
First Author: Murray NR
Year: 2004
Journal: J Cell Biol
Title: Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo.
Volume: 164
Issue: 6
Pages: 797-802
•
•
•
•
•
Publication
28330997 | J:243129
First Author: Wang YA
Year: 2017
Journal: Mol Cancer Res
Title: IGFBP3 Modulates Lung Tumorigenesis and Cell Growth through IGF1 Signaling.
Volume: 15
Issue: 7
Pages: 896-904
•
•
•
•
•
Publication
25038189 | J:222076
First Author: Xu B
Year: 2014
Journal: Am J Physiol Lung Cell Mol Physiol
Title: Promotion of lung tumor growth by interleukin-17.
Volume: 307
Issue: 6
Pages: L497-508
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom